38
Participants
Start Date
March 31, 2012
Primary Completion Date
August 31, 2013
Study Completion Date
August 31, 2013
Bevacizumab
Medical Treatment
Care treatment included topical eyedrops of 0.3% tobramycin and 0.1% dexamethasone (Trazidex, Laboratorios Sophia) three times daily, and 0.5 carboxymethylcellulose lubricating eye drops (Refresh-Tears, Allergan, Irving, California, USA). Topical antibiotics and corticosteroids were tapered and discontinued after two weeks.
Medical Treatment
Care treatment included topical eyedrops of 0.3% tobramycin and 0.1% dexamethasone (Trazidex, Laboratorios Sophia) three times daily, and 0.5 carboxymethylcellulose lubricating eye drops (Refresh-Tears, Allergan, Irving, California, USA). Topical antibiotics and corticosteroids were tapered and discontinued after two weeks.
Argon laser treatment
Institute of Ophthalmology, Conde de Valenciana Foundation, Mexico City
National Council of Science and Technology, Mexico
OTHER
Instituto de Oftalmología Fundación Conde de Valenciana
OTHER